Finland· FI-REL-REL49329

Erlotinib Mylan

A erlotinib product containing erlotinib hydrochloride, registered in Finland by Mylan AB. The same ATC class is registered in 14 of our 19 countries.

ATC L01EB02

Checked against Fimea (Finland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about erlotinib hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Erlotinib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EB02 (erlotinib), each read from that country’s own register.

This record: Finland, from Fimea (Finland)
8 of them publish a price we can compare per daily dose

Search erlotinib products by name

Erlotinib · ATC L01EB02

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of erlotinib costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Erlotinib · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

CH Switzerland$102.78

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)

Active substance: Erlotinib hydrochloride
Manufacturer: Mylan AB
Country: Finland (FI)
ATC code: L01EB02
ATC class: Erlotinib
Defined daily dose: 0.15 g, O
Reimbursed: Not published by this register
Source register: Fimea (Finland)
Last checked: September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

355 interactions on record for erlotinib.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check erlotinib against other medicines How interaction checks work

Erlotinib · interactions on record

355 records

14 severe
192 moderate
2 minor
147 info

Most severe, free to view

OmeprazoleA02BC01severe
PantoprazoleA02BC02severe
LansoprazoleA02BC03severe
RabeprazoleA02BC04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Erlotinib in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erlotinib products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Belgium · Erlotinib Sandoz
Bulgaria · Ерлотиниб Актавис, Ерлотиниб Крка
Cyprus · Erlotinib Remedica
Czechia · Erlotinib Krka, Erlotinib Teva
Germany · Erlotev, Erlotinib Axiromed
Denmark · Erlotinib "stada", Erlotinib Krka
Estonia · Erlotinib Viatris
Spain · Erlotinib Sandoz, Erlotinib Tarbis
France · Erlotinib Biogaran, Erlotinib Eg
United Kingdom (Northern Ireland) · Erlotinib Amarox, Erlotinib Glenmark
Greece · Erlotinib Faran, Erlotinib Teva
Croatia · Erlotinib Alpha-Medical, Erlotinib Krka
Hungary · Erlotinib Actavis, Erlotinib Krka
Iceland · Erlotinib Krka, Erlotinib Teva
Italy · Erlotinib Mylan, Erlotinib Sandoz
Liechtenstein · Tarceva
Lithuania · Erlotinib Viatris, Varlota
Latvia · Erlotinib Sandoz, Erlotinib Viatris
Netherlands · Erlotinib Accordpharma, Erlotinib Amarox
Norway · Erlotinib Krka, Tarceva
Poland · Erlotinib Zentiva
Portugal · Erlotinib Mylan, Erlotinib Qritou
Romania · Erlotinib Krka, Erlotinib Viatris
Sweden · Erlotinib Krka, Erlotinib Medical Valley
Slovenia · Erlotinib Krka, Erlotinib Teva
Slovakia · Erlotinib Sandoz, Erlotinib Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/0004871a-75ad-4e8a-abbe-786f5625d241
GET /v1/drugs/0004871a-75ad-4e8a-abbe-786f5625d241?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.15",
  "form": "tabletti, kalvopäällysteinen",
  "route": null,
  "ddd_unit": "g",
  "strength": "150 mg",
  "atc_label": "erlotinibi",
  "ma_number": "34299",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL49329",
  "authorised_at": "2017-06-30"
}

API reference MCP server Plans

See everything about erlotinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console